title: Cholesterol levels in untreated Spanish hypertensive patients. The Compas Study Group, Spanish Hypertension Society.
abstract: In daily practice, arterial hypertension (AHT) and hypercholesterolaemia are frequently associated with the existence of multiple common etiopathogenic interrelationships. This situation leads to an exponential increase in cardiovascular risk for these patients, so it is essential to know the prevalence and therapeutic management of hypercholesterolaemia in the hypertensive patient. This national study analyses the distribution of total cholesterol levels and low-density lipoprotein cholesterol as well as hypercholesterolaemia prevalence and its therapeutic management in the uncontrolled hypertensive Spanish population. We observed mean total cholesterol levels of 227+/-41 mg/dl with a high prevalence of hypercholesterolaemia (34.2%) among hypertensive patients, and the percentage of those patients with "desirable" total cholesterol levels (<200 mg/dl) was <25%. The treated hypertensive patients presented both significantly higher mean cholesterol levels and greater hypercholesterolaemia prevalence than the untreated hypertensive patients. It appears that total cholesterol levels are scarcely related to the presence or non-presence of obesity, diabetes or smoking. Regarding treatment, only 14.6% of the hypercholesterolaemic hypertensive patients received hypolipaemic treatment with statins. These results support the need to introduce measures for better diagnostic and therapeutic management of hypercholesterolaemic hypertensive patients that will lead to a much higher reduction in cardiovascular risk for these patients.
authors.affiliation: Hypertension Unit, Carlos Haya General Hospital, Málaga, Spain. parand@farmanet.com
authors.forename: P
authors.initials: P
authors.lastname: Aranda
authors.forename: J L
authors.initials: JL
authors.lastname: Rodicio
authors.forename: M
authors.initials: M
authors.lastname: Luque
authors.forename: J R
authors.initials: JR
authors.lastname: Banegas
authors.forename: R
authors.initials: R
authors.lastname: Barajas
authors.forename: F J
authors.initials: FJ
authors.lastname: Aranda
authors.forename: P
authors.initials: P
authors.lastname: Sobrino
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013030:Spain
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D002784:Cholesterol